Paper28294567
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
Conte E and 21 others. J Cachexia Sarcopenia Muscle, 2017. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia. Papers, record 28294567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28294567
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cachexia | Major topic |
| Calcium | Major topic |
| Cisplatin | Major topic |
| Ghrelin | Major topic |
| Homeostasis | Major topic |
| Muscle, Skeletal | Major topic |
| Animals | |
| Biomarkers | |
| Body Weight | |
| Disease Models, Animal | |
| Gene Expression Profiling | |
| Male | |
| Muscle Strength | |
| Muscular Atrophy | |
| Rats |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24610533 | Cachectic skeletal muscle response to a novel bout of low-frequency stimulation. | J Appl Physiol (1985) | 2014 | https://conductscience.org/library/papers/24610533 | PubMed |
| 2 | 17927165 | Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. | J Med Chem | 2007 | https://conductscience.org/library/papers/17927165 | PubMed |
| 3 | 21475697 | Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. | J Cachexia Sarcopenia Muscle | 2010 | https://conductscience.org/library/papers/21475697 | PubMed |
| 4 | 17992259 | The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17992259 | PubMed |
| 5 | 12923063 | Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle. | FASEB J | 2003 | https://conductscience.org/library/papers/12923063 | PubMed |
| 6 | 22542715 | Regulation and physiological roles of the calpain system in muscular disorders. | Cardiovasc Res | 2012 | https://conductscience.org/library/papers/22542715 | PubMed |
| 7 | 12788817 | Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor. | Br J Pharmacol | 2003 | https://conductscience.org/library/papers/12788817 | PubMed |
| 8 | 9882739 | Regulation of the human skeletal muscle chloride channel hClC-1 by protein kinase C. | J Physiol | 1999 | https://conductscience.org/library/papers/9882739 | PubMed |
| 9 | 24823295 | Mechanisms of cisplatin-induced muscle atrophy. | Toxicol Appl Pharmacol | 2014 | https://conductscience.org/library/papers/24823295 | PubMed |
| 10 | 19246619 | The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. | Clin Chem | 2009 | https://conductscience.org/library/papers/19246619 | PubMed |
| 11 | 26832124 | In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography. | Sci Rep | 2016 | https://conductscience.org/library/papers/26832124 | PubMed |
| 12 | 21296615 | Definition and classification of cancer cachexia: an international consensus. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21296615 | PubMed |
| 13 | 21803290 | Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. | Cell Metab | 2011 | https://conductscience.org/library/papers/21803290 | PubMed |
| 14 | 15951398 | Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/15951398 | PubMed |
| 15 | 23649607 | A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation–contraction coupling together with additional muscle alterations. | Muscle Nerve | 2014 | https://conductscience.org/library/papers/23649607 | PubMed |
| 16 | 17962345 | Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia. | Endocrinology | 2008 | https://conductscience.org/library/papers/17962345 | PubMed |
| 17 | 17375904 | Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1. | J Med Chem | 2007 | https://conductscience.org/library/papers/17375904 | PubMed |
| 18 | 25084345 | Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats: cytofluorimetric and gene expression analysis. | Am J Pathol | 2014 | https://conductscience.org/library/papers/25084345 | PubMed |
| 19 | 17293561 | Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system. | J Pharmacol Exp Ther | 2007 | https://conductscience.org/library/papers/17293561 | PubMed |
| 20 | 21986958 | Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat. | Amino Acids | 2012 | https://conductscience.org/library/papers/21986958 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42924648 | Melatonin and Cisplatin-Associated Skeletal Muscle Wasting and Atrophy: Mechanistic Rationale, Current Evidence, and Research Gaps. | Muscles | 2026 | https://conductscience.org/library/papers/42924648 | PubMed |
| 42249926 | Exercise attenuates cisplatin-induced anorexia-cachexia via modulation of hypothalamic inflammation and orexigenic signaling. | Eur J Appl Physiol | 2026 | https://conductscience.org/library/papers/42249926 | PubMed |
| 41419070 | The effects of tissue inflammation on cancer cachexia. | Biochim Biophys Acta Mol Basis Dis | 2026 | https://conductscience.org/library/papers/41419070 | PubMed |
| 41300501 | N-Acetylcysteine Prevents Skeletal Muscle Cisplatin-Induced Atrophy by Inducing Myogenic microRNAs and Maintaining the Redox Balance. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41300501 | PubMed |
| 40600951 | Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting. | J Exp Med | 2025 | https://conductscience.org/library/papers/40600951 | PubMed |
| 40343378 | Cisplatin-Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/40343378 | PubMed |
| 39636147 | Diversity in chemotherapy-induced cachexia. | Am J Physiol Cell Physiol | 2025 | https://conductscience.org/library/papers/39636147 | PubMed |
| 38962308 | Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38962308 | PubMed |
| 38708546 | Biological sex impacts oxidative stress in skeletal muscle in a porcine heat stress model. | Am J Physiol Regul Integr Comp Physiol | 2024 | https://conductscience.org/library/papers/38708546 | PubMed |
| 38294698 | Metabolic underpinnings of cancer-related fatigue. | Am J Physiol Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38294698 | PubMed |
| 38145833 | Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38145833 | PubMed |
| 37776278 | Grip strength in patients with galactosemia and in a galactose-1-phosphate uridylyltransferase (GALT)-null rat model. | J Inherit Metab Dis | 2023 | https://conductscience.org/library/papers/37776278 | PubMed |
| 36902405 | Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902405 | PubMed |
| 36674509 | Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674509 | PubMed |
| 36561625 | Nomegestrol acetate ameliorated adipose atrophy in a rat model of cisplatin‑induced cachexia. | Exp Ther Med | 2023 | https://conductscience.org/library/papers/36561625 | PubMed |
| 36401337 | Capsaicin alleviates cisplatin-induced muscle loss and atrophy in vitro and in vivo. | J Cachexia Sarcopenia Muscle | 2023 | https://conductscience.org/library/papers/36401337 | PubMed |
| 36111771 | Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis. | Curr Neuropharmacol | 2023 | https://conductscience.org/library/papers/36111771 | PubMed |
| 36010642 | Metabolic Pathways and Ion Channels Involved in Skeletal Muscle Atrophy: A Starting Point for Potential Therapeutic Strategies. | Cells | 2022 | https://conductscience.org/library/papers/36010642 | PubMed |
| 35521962 | Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia. | Exp Biol Med (Maywood) | 2022 | https://conductscience.org/library/papers/35521962 | PubMed |
| 34871336 | Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury. | Drug Target Insights | 2021 | https://conductscience.org/library/papers/34871336 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CA2 | 760 | PubTator's text mining | https://conductscience.org/library/genes/760 | NCBI Gene |
| CLCN1 | 1180 | PubTator's text mining | https://conductscience.org/library/genes/1180 | NCBI Gene |
| ORAI1 | 84876 | PubTator's text mining | https://conductscience.org/library/genes/84876 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
| QDPR | 5860 | PubTator's text mining | https://conductscience.org/library/genes/5860 | NCBI Gene |
| RYR1 | 6261 | PubTator's text mining | https://conductscience.org/library/genes/6261 | NCBI Gene |
| STIM1 | 6786 | PubTator's text mining | https://conductscience.org/library/genes/6786 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28294567
GET https://conductscience.org/api/papers/v1/28294567/authors?page=2